For the first time, advanced prostate cancer has been treated based on the genomic makeup of the cancer, delaying disease progression for patients with a treatment-resistant form of prostate cancer.
Monthly Archives: April, 2020
Northwestern Medicine experts discuss the phenomenon of “caution fatigue,” where people may find it difficult to stay on high-risk alert after weeks of social distancing and isolation to stop the spread of COVID-19.
Ben Smith, a second-year medical student, led a study that found opioid prescriptions declined significantly between 2013 and 2018 in the Northwestern Memorial Hospital Emergency Department.
A novel drug called luspatercept may reduce blood transfusion burden for patients with transfusion-dependent beta-thalassemia, an inherited blood disorder.
A newly developed high-resolution brain mapping technology exceeds the lifespans of current platforms and may enhance how brain function is measured and how efficiently neurological diseases are diagnosed and treated.
A new study has found that genetic alterations in a rare form of leukemia physically change the architecture of DNA, fueling the replication and spread of cancer cells.
There are variety of ways improve care delivery, interpret new information, and maintain clinical trials and experiments in the face of the COVID-19 pandemic, according to recent editorials published by Feinberg faculty.
Northwestern Medicine investigators have discovered that eye movements are tightly linked to learning and retrieval, according to new findings.
Students are conducting telehealth visits and reaching out to patients at high risk of complications from COVID-19, part of the transition of the Education Centered Medical Home to virtual care.
A specialized subset of rare immune cells called plasmacytoid dendritic cells may promote antitumor immunity, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.